Navigation Links
Cancer Survivor & Award-Winning Journalist, Jamie Reno, Announces Genelux Corporation's Advancement in Cancer Research
Date:7/19/2013

San Diego, CA (PRWEB) July 19, 2013

Jamie Reno, an award-winning journalist, cancer survivor and patient advocate, discussed in depth the discoveries by a small biotech firm in San Diego that has been flying under the radar for the past decade. What’s the big discovery? They may have found the cure for cancer.

While Genelux is currently conducting Phase I/II human trials for this virus at Moores, Sloan Kettering, Royal Marsden Hospital in London, and the Tubingen University Hospital in Germany, most people have not heard of this treatment, or this company. The virus-based treatment developed by Genelux, a company founded in 2001 that has offices in California and Europe, could completely change the perspective and approach on cancer care. Genelux, which has received very little publicity, has developed a virus-based treatment called GL-ONC1 that kills cancer cells throughout the body safely and effectively.

While there are plenty of so-called wonderdrugs that kill cancer in mice but do not work in people, the virus-based treatment from Genelux has been proven effective in people. Human trials for GL-ONC1 are already underway at such prestigious cancer institutions as Memorial Sloan-Kettering in New York and the UC San Diego Moores Cancer Center. More than 60 people, mostly patients who have exhausted every other treatment option, have enrolled in these trials for a variety of cancers. And the responses have been amazing.

Reno is not big on hype and hyperbole when it comes to cancer treatments, but the inspirational story of Genelux can serve as a beacon of hope for those who suffer from cancer, and often times, the toxic treatment that follows. Reno believes their work could result in an entirely new paradigm in the field of oncology and delivery of medicine in general.

The virus, which was used in the first smallpox vaccine nearly two centuries ago, is delivered intravenously, and then navigates through the body’s immune response to reach its target. It intelligently locates and kills all cancer cells throughout the body (solid tumors, liquid tumors, cancer stem cells, and metastasis). The treatment is very safe and there are no side effects other than very mild fever for and some chills for a few hours at most.

Using a virus to treat cancer is not a new study; it has been around for several decades. Besides vaccine, other oncolytic viruses used in clinical trials are adenovirus, reovirus, measles, herpes simplex and Newcastle disease viruses. But Genelux has taken it to new heights with this treatment, which could even be a cure.

About: Jamie Reno, an award-winning correspondent for Newsweek for 20 years, has also written for The Daily Beast, The New York Times, Sports Illustrated, Rolling Stone, People, Men’s Journal, ESPN, Los Angeles Times, TV Guide, MSNBC, Newsmax, Entertainment Weekly, and USA Today. Reno has won more than 95 writing awards including the National Magazine Award for General Excellence, the highest award in magazine journalism. Reno is also a three-time, 17-year survivor of stage IV non-Hodgkin's lymphoma. He has written two acclaimed books on cancer survivorship and is always on the lookout for new cancer treatments. He lives in San Diego with his wife, Gabriela, and their daughter, Mandy.

If you're a cancer patient or just want more information on Genelux or other companies that offer new, innovative cancer treatments, contact Jamie Reno directly.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10938602.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New plan of attack in cancer fight
2. Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
3. AAHD Helps in Your Fight Against Breast Cancer
4. Arena Football League (AFL) Kicker Kyle Brotzman Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer
5. Thwarting protein production slows cancer cells malignant march
6. Cancer prehabilitation can reduce complications and improve treatment outcomes
7. Menopause symptoms worse in cancer survivors
8. Texas Man Suffering from Bladder Cancer Because of Actos Use, Alleges Lawsuit Filed by Parker Waichman LLP
9. Intelligent knife tells surgeon which tissue is cancerous
10. TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping
11. Cosmetics and Beauty Products Could Cause Cancer: New Website Explores Evidence Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology: